Vilon (Lys-Glu)
Overview
Vilon is a synthetic dipeptide consisting of lysine and glutamic acid (Lys-Glu) developed as part of the Khavinson bioregulator peptide research program. The peptide is proposed to interact with DNA regulatory regions to modulate gene expression related to immune function and cellular repair. Vilon has been studied primarily in Russian research for immunomodulation and potential geroprotective properties. The mechanism is postulated to involve epigenetic regulation, though detailed molecular characterization remains incomplete.
Key Research Findings
Preclinical studies in rodents have reported that Vilon administration increases lifespan and enhances immune parameters in aging animals. Published clinical evidence is limited to small studies in Russian journals describing immunological effects in elderly subjects, without large randomized controlled trials. Independent replication and validation in international peer-reviewed settings have not been performed, and Vilon lacks regulatory approval outside of Russia.
Subcutaneous injection, Oral
Investigational
Interested in Vilon (Lys-Glu)?
Find a verified provider experienced with Vilon (Lys-Glu) protocols in your area. All providers are credentialed and use compliant sourcing.
Find a Vilon (Lys-Glu) ProviderRelated Peptides
Epithalon (Epitalon)
Research PhaseA synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on the natural epithalamin peptide produced by the pineal gland. Epithalon activates telomerase, the enzyme responsible for maintaining telomere length, thereby potentially extending cellular replicative capacity. It also stimulates melatonin production and modulates neuroendocrine system function associated with aging.
MOTS-c
Research PhaseA mitochondrial-derived peptide encoded by the 12S rRNA gene of mitochondrial DNA. MOTS-c is a 16-amino acid peptide that acts as an exercise mimetic by activating AMPK and regulating metabolic homeostasis. It translocates to the nucleus under metabolic stress to regulate nuclear gene expression related to glucose metabolism and cellular stress responses.
Humanin
Research PhaseA 24-amino acid mitochondrial-derived peptide encoded within the 16S rRNA region of mitochondrial DNA. Humanin exerts cytoprotective and neuroprotective effects by interacting with IGFBP-3, BAX, and the FPRL-1 receptor. It inhibits apoptosis through suppression of the intrinsic mitochondrial death pathway and reduces amyloid-beta-induced neurotoxicity.
NAD+ Precursors (NMN)
In Clinical TrialsNicotinamide mononucleotide (NMN) is a direct biosynthetic precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for cellular metabolism, DNA repair (via sirtuins and PARPs), and circadian rhythm regulation. NAD+ levels decline with age, and NMN supplementation restores tissue NAD+ levels, activating SIRT1-mediated pathways that regulate mitochondrial biogenesis and oxidative stress resistance.